A compartment model analysis for investigation of myocardial fatty acid metabolism in patients with hypertrophic cardiomyopathy

Nuclear Medicine Communications

Volumn 28, Issue 9, 2007, Pages 726-735

  Okizaki, Atsutaka ^a   Shuke, Noriyuki ^a   Sato, Junichi ^a   Sasaki, Tomoaki ^a   Hasebe, Naoyuki ^b   Kikuchi, Kenjiro ^b   Aburano, Tamio ^b  

^a Department of Radiology ^*  (Japan)

^b ASAHIKAWA MEDICAL COLLEGE   (Japan)

Author keywords

Compartment model analysis; Dynamic SPECT; Hypertrophic cardiomyopathy; Left ventricular hyperplasia

Indexed keywords

15 (4 IODOPHENYL) 3 METHYLPENTADECANOIC ACID I 123; FATTY ACID; TETROFOSMIN TC 99M;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPARTMENT MODEL; CONTROLLED STUDY; DRUG UPTAKE; FATTY ACID METABOLISM; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MALE; MATHEMATICAL COMPUTING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ADULT; AGED; CARDIOMYOPATHY, HYPERTROPHIC; DISEASE PROGRESSION; ECHOCARDIOGRAPHY; FATTY ACIDS; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IODINE RADIOISOTOPES; KINETICS; MALE; MIDDLE AGED; MODELS, THEORETICAL; MYOCARDIUM; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 34547676288     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/MNM.0b013e32828da1c7     Document Type: Article

References (40)

1. Neely JR, Rovetto MJ, Oram JF. Myocardial utilization of carbohydrate and lipids. Prog Cardiovasc Dis 1972; 15:289-329.
2. Bing RJ. Cardiac metabolism. Physiol Rev 1965; 45:171-213.
3. Opie LH. Metabolism of the heart in health and disease. I. Am Heart J 1968; 76:685-698.
4. 11C-palmitate. Circulation 1977; 55:853-857.
5. Tadamura E, Tamaki N, Matsumori A, Magata Y, Yonekura Y, Nohara R, et al. Myocardial metabolic changes in hypertrophic cardiomyopathy. J Nucl Med 1996; 37:572-577.
6. 123I-15-(p-iodophenyl)-9-R, S-methylpentadecanoic acid in acute coronary syndrome. J Nucl Med 1999; 40:1999-2006.
7. Knapp FF Jr, Ambrose KR, Goodman MM. New radioiodinated methyl-branched fatty acids for cardiac studies. Eur J Nucl Med 1986; 12(suppl):S39-S44.
8. Tamaki N, Fujibayashi Y, Magata Y, Yonekura Y, Konishi J. Radionuclide assessment of myocardial fatty acid metabolism by PET and SPECT. J Nucl Cardiol 1995; 2:256-266.
9. Goodman MM, Kirsch G, Knapp FF Jr. Synthesis and evaluation of radioiodinated terminal p-iodophenyl-substituted alpha- and beta-methyl-branched fatty acids. J Med Chem 1984; 27:390-397.
10. Tadamura E, Kudoh T, Hattori N, Inubushi M, Magata Y, Konishi J, et al. Impairment of BMIPP uptake precedes abnormalities in oxygen and glucose metabolism in hypertrophic cardiomyopathy. J Nucl Med 1998; 39:390-396.
11. 123I-labeled 15-(p-iodophenyl)-3R, S-methylpentadecanoic acid in hypertrophic cardiomyopathy with asymmetric septal hypertrophy]. Kaku Igaku 1995; 32:377-385 (in Japanese).
12. Kurata C, Tawarahara K, Taguchi T, Aoshima S, Kobayashi A, Yamazaki N, et al. Myocardial emission computed tomography with iodine-123-labeled beta-methyl-branched fatty acid in patients with hypertrophic cardiomyopathy. J Nucl Med 1992; 33:6-13.
13. 123I-BMIPP single-photon emission tomography to estimate areas at risk following successful revascularization in patients with acute myocardial infarction. Eur J Nucl Med 1998; 25:1390-1395.
14. 123I-BMIPP in patients with stable effort angina pectoris. Nucl Med Commun 1995; 16:1002-1008.
15. Sasaki R, Mitani I, Usui T, Kitamura Y, Yoshii Y, Ishikawa T, et al. Clinical value of iodine-123 beta-methyliodophenyl pentadecanoic acid (BMIPP) myocardial single photon emission computed tomography for predicting cardiac death among patients with chronic heart failure. Circ J 2003; 67:918-924.
16. Kobayashi H, Nakata T, Han S, Takahashi N, Hashimoto A, Tsuchihashi K, et al. [Fatty acid metabolic and perfusion abnormalities in hypertrophied myocardium assessed by dual tracer tomography using thallium-201 and iodine-123-beta-methylpentadecanoic acid]. J Cardiol 1994; 24:35-43.
17. Saito K, Takeda K, Okamoto S, Okamoto R, Makino K, Tameda Y, et al. Detection of doxorubicin cardiotoxicity by using iodine-123 BMIPP early dynamic SPECT: quantitative evaluation of early abnormality of fatty acid metabolism with the Rutland method. J Nucl Cardiol 2000; 7:553-561.
18. Kitagawa K, Takeda K, Saito K, Okamoto S, Makino K, Maeda H, et al. Differences in fatty acid metabolic disorder between ischemic myocardium and doxorubicin-induced myocardial damage: assessment using BMIPP dynamic SPECT with analysis by the Rutland method. J Nucl Med 2002; 43:1286-1294.
19. 123I-BMIPP. J Gastroenterol 2000; 35:127-135.
20. 123I-16-iodo-9-hexadecenoic acid in an isolated rat heart. Validation by comparison with experimental measurements. Eur J Nucl Med 1986; 11:453-458.
21. Sakamoto T, Aoki M, Imai Y, Nemoto S. Carnitine affects fatty acid metabolism after cardioplegic arrest in neonatal rabbit hearts. Ann Thorac Surg 2001; 71:648-653.
22. Richardson P, McKenna W, Bristow M, Maisch B, Mautner B, O'Connell J, et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. Circulation 1996; 93:841-842.
23. McKenna WJ, Spirito P, Desnos M, Dubourg O, Komajda M. Experience from clinical genetics in hypertrophic cardiomyopathy: proposal for new diagnostic criteria in adult members of affected families. Heart 1997; 77:130-132.
24. Adachi I, Morita K, Imran MB, Konno M, Mochizuki T, Kubo N, et al. Heterogeneity of myocardial wall motion and thickening in the left ventricle evaluated with quantitative gated SPECT. J Nucl Cardiol 2000; 7:296-300.
25. Germano G, Kiat H, Kavanagh PB, Moriel M, Mazzanti M, Su HT, et al. Automatic quantification of ejection fraction from gated myocardial perfusion SPECT. J Nucl Med 1995; 36:2138-2147.
26. Narita M, Kurihara T. Is I-123-beta-methyl-p-iodophenyl-methylpentadecanoic acid imaging useful to evaluate asymptomatic patients with hypertrophic cardiomyopathy? I-123 BMIPP imaging to evaluate asymptomatic hypertrophic cardiomyopathy. Int J Cardiovasc Imaging 2003; 19:499-510.
27. 123I-BMIPP). Nucl Med Commun 1994; 15:441-447.
28. Mori T, Yamabe H, Yokota Y, Fukuzaki H. Clinical significance of dipyridamole Tl-201 emission computed tomography perfusion abnormality for evaluating pathophysiological and pathological aspects in hypertrophic cardiomyopathy. Jpn Circ J 1988; 52:111-118.
29. Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 2002; 105:539-542.
30. Akaike H. Information theory and an extension of the maximum likelihood principle. Proceedings of the 2nd International Symposium on Information Theory. Budapest: Akadimiai Kiado; 1973. 267-281.
31. Fujibayashi Y, Nohara R, Hosokawa R, Okuda K, Yonekura Y, Tamaki N, et al. Metabolism and kinetics of iodine-123-BMIPP in canine myocardium. J Nucl Med 1996; 37:757-761.
32. 123I-BMIPP in a canine model with ischemia: implications of perfusion-metabolism mismatch on SPECT images in patients with ischemic heart disease. J Nucl Med 1999; 40:471-478.
33. 125I-BMIPP in rats treated with adriamycin]. Kaku Igaku 1989; 26:69-76 (in Japanese).
34. Fujibayashi Y, Yonekura Y, Takemura Y, Wada K, Matsumoto K, Tamaki N, et al. Myocardial accumulation of iodinated beta-methyl-branched fatty acid analogue, iodine-125-15-(p-iodophenyl)-3-(R, S)methylpentadecanoic acid (BMIPP), in relation to ATP concentration. J Nucl Med 1990; 31:1818-1822.
35. 125I-BMIPP autoradiography. Ann Nucl Med 2004; 18:195-202.
36. Oliver MF, Kurien VA, Greenwood TW. Relation between serum-free-fatty acids and arrhythmias and death after acute myocardial infarction. Lancet 1968; 1:710-714.
37. Corr PB, Gross RW, Sobel BE. Amphipathic metabolites and membrane dysfunction in ischemic myocardium. Circ Res 1984; 55:135-154.
38. Katz AM, Messineo FC. Lipid-membrane interactions and the pathogenesis of ischemic damage in the myocardium. Circ Res 1981; 48:1-16.
39. Lopaschuk GD, Belke DD, Gamble J, Itoi T, Schonekess BO. Regulation of fatty acid oxidation in the mammalian heart in health and disease. Biochim Biophys Acta 1994; 1213:263-276.
40. 1H NMR spectroscopic imaging of myocardial triglycerides in excised dog hearts subjected to 24 hours of coronary occlusion. Circulation 1996; 93:1464-1470.